Propofol Cardioprotection against Myocardial Ischemia-Reperfusion Injury: A Mechanistic Review

Authors

  • Xiaowen Mao Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Zhi-dong Ge Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Xiang Xie Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Qingquan Lian Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Zhengyuan Xia Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Anesthesiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

Keywords:

Antioxidant, Cardioprotection, Myocardial ischemia reperfusion injury, Nitric oxide, Propofol, Protective survivor activating factor enhancement pathway, Reperfusion injury signaling kinase pathway

Abstract

Reperfusion after prolonged ischemia is necessary to rescue injured hearts while it paradoxically worsens cardiac injury, a phenomenon termed myocardial ischemia-reperfusion injury (MIRI). Overproduction of reactive oxygen species, calcium overload, and inflammation contribute to the pathogenesis of MIRI. Propofol, a commonly used anesthetic with antioxidant property, has been shown to be cardioprotective in experimental studies and in some small clinical trials of cardiac surgery using cardiopulmonary bypass. However, its effectiveness of cardioprotection needs to be confirmed in large clinical trials, and the mechanisms of its action remain a focus of current research. The purpose of this review is to delineate and summarize the mechanism underlying propofol-mediated cardioprotection against MIRI.

Downloads

Published

2016-05-01

How to Cite

Mao, X., Ge, Z.- dong, Xie, X., Lian, Q., & Xia, Z. (2016). Propofol Cardioprotection against Myocardial Ischemia-Reperfusion Injury: A Mechanistic Review. Reactive Oxygen Species, 1(3), 178–188. Retrieved from https://rosj.org/index.php/ros/article/view/34

Issue

Vol. 1 No. 3 (2016)

Section

REVIEW ARTICLES

License

Submission of an original manuscript to the Journal will be taken to mean that it represents original work not previously published; that it is not being considered elsewhere for publication; that the author(s) agrees to assign copyright to the Journal upon acceptance for publication in the Journal, and if accepted for publication, it will be published in the digital format (PDF) and/or in print and it will not be published elsewhere in the same form, for commercial purposes, in any language, without the consent of the Publisher.